To Newsroom
Oriola-KD signed agreements with four pharmacy chains in Sweden on purchasing, warehousing and pharmacy distribution of OTC products and traded goods
29.6.2012
Oriola-KD Corporation Stock Exchange Release 29 June 2012 at 4 p.m. Oriola-KD's Swedish pharmaceutical wholesale business Oriola AB has today signed, based on the letter of intent published on 9 May 2012, agreements with Swedish pharmacy chains Apoteksgruppen, DocMorris, Medstop and Vårdapoteket. Oriola AB provides Apoteksgruppen, DocMorris, Medstop and Vårdapoteket with new and innovative service offerings for the purchasing, warehousing and pharmacy distribution of OTC and traded goods products. The pharmacy chains had the following market shares of the Swedish pharmacy market in 2011: Apoteksgruppen 10.8 %, Medstop 7.7 %, Vårdapoteket 4.4 % and DocMorris 2.4% (KPMG report 01/2012). Purchases of the OTC and traded goods are expected to be some SEK 1 200 million annually starting from 2013. The new services for the pharmacy chains will be launched during the last quarter of 2012. Oriola-KD Corporation Eero Hautaniemi President & CEO For additional information, please contact: Mr. Eero Hautaniemi President & CEO tel. +358 10 429 2109 email: eero.hautaniemi@oriola-kd.com Mr. Joni Ihantola VP, Treasury & IR tel. +358 10 429 4386 email: joni.ihantola@oriola-kd.com Distribution: NASDAQ OMX Helsinki Ltd. Principal media Published by: Oriola-KD Corporation Corporate Communications Orionintie 5 FI-02200 Espoo www.oriola-kd.com [HUG#1623116]